These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 14987293)

  • 1. Calcium sensors as new therapeutic targets for asthma and chronic obstructive pulmonary disease.
    Ten Broeke R; Blalock JE; Nijkamp FP; Folkerts G
    Clin Exp Allergy; 2004 Feb; 34(2):170-6. PubMed ID: 14987293
    [No Abstract]   [Full Text] [Related]  

  • 2. Ca2+ sensors modulate asthmatic symptoms in an allergic model for asthma.
    Ten Broeke R; Brandhorst MC; Leusink-Muis T; Villain M; De Clerck F; Blalock JE; Nijkamp FP; Folkerts G
    Eur J Pharmacol; 2003 Aug; 476(1-2):151-7. PubMed ID: 12969760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcium sensors as new therapeutic targets for airway hyperresponsiveness and asthma.
    Ten Broeke R; Folkerts G; Leusink-Muis T; Van der Linde HJ; Villain M; Manion MK; De Clerck F; Blalock JE; Nijkamp FP
    FASEB J; 2001 Aug; 15(10):1831-3. PubMed ID: 11481245
    [No Abstract]   [Full Text] [Related]  

  • 4. Attenuation of very late antigen-5-mediated adhesion of bone marrow-derived mast cells to fibronectin by peptides with inverted hydropathy to EF-hands.
    Houtman R; Ten Broeke R; Blalock JE; Villain M; Koster AS; Nijkamp FP
    J Immunol; 2001 Jan; 166(2):861-7. PubMed ID: 11145661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific modulation of calmodulin activity induces a dramatic production of superoxide by alveolar macrophages.
    Broeke RT; Leusink-Muis T; Hilberdink R; Van Ark I; van den Worm E; Villain M; De Clerck F; Blalock JE; Nijkamp FP; Folkerts G
    Lab Invest; 2004 Jan; 84(1):29-40. PubMed ID: 14631377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease.
    Louis RE; Cataldo D; Buckley MG; Sele J; Henket M; Lau LC; Bartsch P; Walls AF; Djukanovic R
    Eur Respir J; 2002 Aug; 20(2):325-31. PubMed ID: 12212963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of macrophages in obstructive airways disease: chronic obstructive pulmonary disease and asthma.
    Pappas K; Papaioannou AI; Kostikas K; Tzanakis N
    Cytokine; 2013 Dec; 64(3):613-25. PubMed ID: 24084332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacodynamic evaluation of RP3128, a novel and potent CRAC channel inhibitor in guinea pig models of allergic asthma.
    Sutovska M; Kocmalova M; Franova S; Vakkalanka S; Viswanadha S
    Eur J Pharmacol; 2016 Feb; 772():62-70. PubMed ID: 26724844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of endogenous and exogenous AMP in asthma and chronic obstructive pulmonary disease.
    van den Berge M; Polosa R; Kerstjens HA; Postma DS
    J Allergy Clin Immunol; 2004 Oct; 114(4):737-46. PubMed ID: 15480309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonists and asthma.
    Middleton E
    J Allergy Clin Immunol; 1985 Aug; 76(2 Pt 2):341-6. PubMed ID: 2410477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of pendrin as a common mediator for mucus production in bronchial asthma and chronic obstructive pulmonary disease.
    Nakao I; Kanaji S; Ohta S; Matsushita H; Arima K; Yuyama N; Yamaya M; Nakayama K; Kubo H; Watanabe M; Sagara H; Sugiyama K; Tanaka H; Toda S; Hayashi H; Inoue H; Hoshino T; Shiraki A; Inoue M; Suzuki K; Aizawa H; Okinami S; Nagai H; Hasegawa M; Fukuda T; Green ED; Izuhara K
    J Immunol; 2008 May; 180(9):6262-9. PubMed ID: 18424749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium-channel blockers in prophylaxis and treatment of asthma.
    Fanta CH
    Am J Cardiol; 1985 Jan; 55(3):202B-209B. PubMed ID: 3881915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cells in airway smooth muscle.
    Tunon-de-Lara JM; Berger P; Bégueret H
    N Engl J Med; 2002 Sep; 347(13):1040-1; author reply 1040-1. PubMed ID: 12324567
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of macrophage activation by calcium channel blockers and calmodulin antagonists.
    Wright B; Zeidman I; Greig R; Poste G
    Cell Immunol; 1985 Oct; 95(1):46-53. PubMed ID: 4028171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of inflammatory cell function by corticosteroids.
    Belvisi MG
    Proc Am Thorac Soc; 2004; 1(3):207-14. PubMed ID: 16113436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of calcium-channel blockers in obstructive airway disease.
    Ahmed T; Abraham WM
    Chest; 1985 Aug; 88(2 Suppl):142S-151S. PubMed ID: 2410203
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences of inflammatory mechanisms in asthma and COPD.
    Ichinose M
    Allergol Int; 2009 Sep; 58(3):307-13. PubMed ID: 19628975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonists affect calmodulin-dependent contractility of a skinned smooth muscle.
    Metzger H; Stern HO; Pfitzer G; Rüegg JC
    Arzneimittelforschung; 1982; 32(11):1425-7. PubMed ID: 6891247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells.
    Hodge S; Hodge G; Scicchitano R; Reynolds PN; Holmes M
    Immunol Cell Biol; 2003 Aug; 81(4):289-96. PubMed ID: 12848850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of airway epithelial cell culture to unravel the pathogenesis and study treatment in obstructive airway diseases.
    Mertens TCJ; Karmouty-Quintana H; Taube C; Hiemstra PS
    Pulm Pharmacol Ther; 2017 Aug; 45():101-113. PubMed ID: 28502841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.